Anagenics Limited (ASX:AN1)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Sep 4, 2026, 11:36 AM AEST
Anagenics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 0.58 | 0.4 | 1.62 | 2.57 | 3.28 |
Cash & Short-Term Investments | 0.58 | 0.4 | 1.62 | 2.57 | 3.28 |
Cash Growth | 45.99% | -75.64% | -36.74% | -21.85% | -51.18% |
Accounts Receivable | 0.81 | 0.57 | 0.65 | 0.75 | 0.83 |
Other Receivables | - | - | - | 0.3 | 0.09 |
Receivables | 0.81 | 0.57 | 0.65 | 1.04 | 0.92 |
Inventory | 1.03 | 0.97 | 1.48 | 2.4 | 4.45 |
Prepaid Expenses | 0.33 | - | - | - | 0.12 |
Other Current Assets | - | - | 0.08 | 0.24 | - |
Total Current Assets | 2.74 | 1.94 | 3.83 | 6.25 | 8.77 |
Property, Plant & Equipment | 0.05 | 0.21 | 0.41 | 0.84 | 0.58 |
Goodwill | 1.95 | 1.95 | 1.95 | 3.45 | 3.45 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0.13 |
Other Long-Term Assets | - | - | - | 0.58 | - |
Total Assets | 4.75 | 4.1 | 6.19 | 11.11 | 12.92 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.32 | 1.06 | 1.69 | 0.72 | 0.5 |
Accrued Expenses | - | - | - | - | 0.22 |
Short-Term Debt | - | 0.54 | 0.27 | - | - |
Current Portion of Long-Term Debt | - | - | - | - | 0.56 |
Current Portion of Leases | 0.03 | 0.22 | 0.2 | 0.19 | 0.34 |
Current Unearned Revenue | 0.01 | 0.04 | 0.1 | 0.18 | - |
Other Current Liabilities | 0.17 | 0.32 | 0.9 | 0.62 | 2.03 |
Total Current Liabilities | 0.52 | 2.19 | 3.17 | 1.71 | 3.66 |
Long-Term Debt | - | - | - | - | 0.77 |
Long-Term Leases | - | 0.09 | 0.3 | 0.46 | 0.09 |
Pension & Post-Retirement Benefits | - | - | - | - | 0.04 |
Other Long-Term Liabilities | - | - | 0.01 | 0.04 | 0.09 |
Total Liabilities | 0.52 | 2.28 | 3.48 | 2.22 | 4.64 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 69.28 | 67.18 | 66.83 | 65.36 | 62.44 |
Retained Earnings | -64.99 | -65.3 | -64.06 | -56.57 | -53.9 |
Comprehensive Income & Other | -0.07 | -0.06 | -0.06 | 0.11 | -0.24 |
Shareholders' Equity | 4.23 | 1.83 | 2.71 | 8.9 | 8.29 |
Total Liabilities & Equity | 4.75 | 4.1 | 6.19 | 11.11 | 12.92 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.03 | 0.85 | 0.77 | 0.65 | 1.76 |
Net Cash (Debt) | 0.54 | -0.45 | 0.85 | 1.91 | 1.53 |
Net Cash Growth | - | - | -55.49% | 25.20% | -71.14% |
Net Cash Per Share | 0.00 | -0.00 | 0.00 | 0.01 | 0.01 |
Filing Date Shares Outstanding | 985.45 | 496.32 | 461.32 | 365.62 | 221.02 |
Total Common Shares Outstanding | 985.45 | 496.32 | 461.32 | 365.62 | 221.02 |
Working Capital | 2.22 | -0.25 | 0.66 | 4.53 | 5.11 |
Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 |
Tangible Book Value | 2.27 | -0.13 | 0.76 | 5.45 | 4.71 |
Tangible Book Value Per Share | 0.00 | -0.00 | 0.00 | 0.01 | 0.02 |
Machinery | - | - | - | - | 0.38 |